-
As both drugs get off U.S. shortage list, Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly
The U.S. FDA has said compounding pharmacies and other entities that have been allowed to make off-brand, cheaper copies of the drugs during the shortage will have to wind down production.